[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum

C69H56Cl4N12O5Pt3S3 — CID 163904765

IUPAC[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum
SMILESCl[Pt+2]Cl.Cl[Pt]Cl.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C(C/N=C/c1ccccc1O)/N=C/c1ccccc1O.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C1CNC(c2ccccn2)=N1.[CH2-]C(C[NH-])C(=O)Nc1ccc(-c2nc3ccccc3s2)cc1.[Pt]
InChIInChI=1S/C30H24N4O3S.C22H17N5OS.C17H15N3OS.4ClH.3Pt/c35-26-10-4-1-7-21(26)17-31-19-25(32-18-22-8-2-5-11-27(22)36)29(37)33-23-15-13-20(14-16-23)30-34-24-9-3-6-12-28(24)38-30;28-21(18-13-24-20(26-18)17-6-3-4-12-23-17)25-15-10-8-14(9-11-15)22-27-16-5-1-2-7-19(16)29-22;1-11(10-18)16(21)19-13-8-6-12(7-9-13)17-20-14-4-2-3-5-15(14)22-17;;;;;;;/h1-18,25,35-36H,19H2,(H,33,37);1-12,18H,13H2,(H,24,26)(H,25,28);2-9,11,18H,1,10H2,(H,19,21);4*1H;;;/q;;-2;;;;;;+2;+4/p-4/b31-17+,32-18+;;;;;;;;;
InChIKeyCOGMDYIUGDONPL-QRJRYDJMSA-J
MW1956.53 g/mol
LogP16.79
Rot. Bonds16

About [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum

[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum (PubChem CID 163904765) has the molecular formula C69H56Cl4N12O5Pt3S3 and a molecular weight of 1956.53 g/mol. Its IUPAC name is [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum.

Molecular Properties

Compound Name[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum
PubChem CID163904765
Molecular FormulaC69H56Cl4N12O5Pt3S3
Molecular Weight1956.53 g/mol
Exact Mass1953.14
IUPAC Name[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum
SMILESCl[Pt+2]Cl.Cl[Pt]Cl.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C(C/N=C/c1ccccc1O)/N=C/c1ccccc1O.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C1CNC(c2ccccn2)=N1.[CH2-]C(C[NH-])C(=O)Nc1ccc(-c2nc3ccccc3s2)cc1.[Pt]
InChIInChI=1S/C30H24N4O3S.C22H17N5OS.C17H15N3OS.4ClH.3Pt/c35-26-10-4-1-7-21(26)17-31-19-25(32-18-22-8-2-5-11-27(22)36)29(37)33-23-15-13-20(14-16-23)30-34-24-9-3-6-12-28(24)38-30;28-21(18-13-24-20(26-18)17-6-3-4-12-23-17)25-15-10-8-14(9-11-15)22-27-16-5-1-2-7-19(16)29-22;1-11(10-18)16(21)19-13-8-6-12(7-9-13)17-20-14-4-2-3-5-15(14)22-17;;;;;;;/h1-18,25,35-36H,19H2,(H,33,37);1-12,18H,13H2,(H,24,26)(H,25,28);2-9,11,18H,1,10H2,(H,19,21);4*1H;;;/q;;-2;;;;;;+2;+4/p-4/b31-17+,32-18+;;;;;;;;;
InChIKeyCOGMDYIUGDONPL-QRJRYDJMSA-J
XLogP16.79
TPSA252.23 Ų
H-Bond Donors6
H-Bond Acceptors16
Rotatable Bonds16
Heavy Atoms96
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001956.53
LogP ≤ 516.79
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;platinum
CID 162702733
N-[4-(1,3-benzothiazol-2-yl)phenyl]oxane-4-carboxamide
CID 31974129
N-[4-(1,3-benzothiazol-2-yl)phenyl]-4-phenylbutanamide
CID 2216354
N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-[(2-chlorophenyl)methylsulfanyl]acetamide
CID 17296174
[(2R)-1-[4-(1,3-benzothiazol-2-yl)anilino]-3-cyano-1-oxopropan-2-yl] carbamate
CID 175341593
N-[4-(1,3-benzothiazol-2-yl)phenyl]-5-bromopentanamide
CID 68701204
2-[4-(1,3-benzothiazol-2-yl)phenoxy]-N-(4-ethoxyphenyl)acetamide
CID 7919369
N-[4-(1,3-benzothiazol-2-yl)phenyl]-4-[(1-hydroxy-2-methylpropyl)amino]butanamide
CID 174362978
N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-cyanoacetamide
CID 168524270
N-[3-[2-[4-(1,3-benzothiazol-2-yl)anilino]-2-oxoethoxy]phenyl]cyclopropanecarboxamide
CID 46409447
4-(1,3-benzothiazol-2-yl)-N-[(Z)-pyridin-2-ylmethylideneamino]benzamide
CID 118730249
2-[2-[4-(1,3-benzothiazol-2-yl)anilino]-2-oxoethoxy]acetic acid
CID 5303623

Frequently Asked Questions

What is the IUPAC name of [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum?
The IUPAC name of [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum (CID 163904765) is [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum.
What is the SMILES notation for [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum?
The canonical SMILES for [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum is Cl[Pt+2]Cl.Cl[Pt]Cl.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C(C/N=C/c1ccccc1O)/N=C/c1ccccc1O.O=C(Nc1ccc(-c2nc3ccccc3s2)cc1)C1CNC(c2ccccn2)=N1.[CH2-]C(C[NH-])C(=O)Nc1ccc(-c2nc3ccccc3s2)cc1.[Pt].
What is the InChIKey of [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum?
The InChIKey is COGMDYIUGDONPL-QRJRYDJMSA-J. The full InChI is InChI=1S/C30H24N4O3S.C22H17N5OS.C17H15N3OS.4ClH.3Pt/c35-26-10-4-1-7-21(26)17-31-19-25(32-18-22-8-2-5-11-27(22)36)29(37)33-23-15-13-20(14-16-23)30-34-24-9-3-6-12-28(24)38-30;28-21(18-13-24-20(26-18)17-6-3-4-12-23-17)25-15-10-8-14(9-11-15)22-27-16-5-1-2-7-19(16)29-22;1-11(10-18)16(21)19-13-8-6-12(7-9-13)17-20-14-4-2-3-5-15(14)22-17;;;;;;;/h1-18,25,35-36H,19H2,(H,33,37);1-12,18H,13H2,(H,24,26)(H,25,28);2-9,11,18H,1,10H2,(H,19,21);4*1H;;;/q;;-2;;;;;;+2;+4/p-4/b31-17+,32-18+;;;;;;;;;.
What are the key properties of [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum?
[3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum has a molecular weight of 1956.53 g/mol, XLogP of 16.79, 16 rotatable bonds, 6 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[4-(1,3-benzothiazol-2-yl)anilino]-2-methanidyl-3-oxopropyl]azanide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2,3-bis[(2-hydroxyphenyl)methylideneamino]propanamide;N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-pyridin-2-yl-4,5-dihydro-1H-imidazole-4-carboxamide;dichloroplatinum;dichloroplatinum(2+);platinum is sourced from PubChem (CID 163904765), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).